-- Days : -- HRS : -- MIN : -- SEC
Register Now →
Opinion|Videos|December 23, 2024

Lp(a) in ASCVD and Guideline Recommendations

Episodes in this series


Related to this article

Kenneth Komorny, PharmD, BCPS | Image: Moffitt Cancer Center
At a Stakeholder Interchange convened by The American Journal of Managed Care® in Tampa, Florida, an academic-community mix of hematologist-oncologists and pharmacists debated prior authorization, site-of-care payment disparities, and how aggressively to push bispecific antibody regimens to community practices treating patients with relapsed/refractory multiple myeloma.